IL10 primarily exerts immunosuppressive effects in the GBM microenvironment by inhibiting effective anti-tumor immune responses and, in some contexts, directly enhancing glioma proliferation via JAK–STAT3 activation (Widodo et al., 2021). Here, STAT3 is linked to central nervous system cancer.